PACB EBITDA Growth
Pacific Biosciences Of California · EBITDA Growth
PACB EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported2.72%period ending
PACB TTM EBITDA YoY % (-16.20% → 2.72%)
Year-over-year change
High-resolution chart · PNG
PACB ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 2.7227% | |
| 54.06% | |
| 37.1031% | |
| 68.612% | |
| 68.3313% | |
| 10.753% | |
| 12.4458% | |
| -14.3882% | |
| -23.7999% | |
| 9.7814% | |
| 1.7027% | |
| -6.9681% | |
| -5.927% | |
| -19.3723% | |
| -12.3921% | |
| -136.0089% | |
| -332.3507% | |
| -400.4083% | |
| -743.9755% | |
| -221.2109% | |
| -57.2335% | |
| -19.3297% | |
| 154.452% | |
| 65.8342% | |
| 60.1908% | |
| 58.9034% | |
| 22.9747% | |
| -24.3845% | |
| -24.9449% | |
| -19.3285% | |
| -14.968% | |
| -4.0484% | |
| -5.4639% | |
| -17.6312% | |
| -19.5227% | |
| -57.4923% | |
| -38.998% | |
| -46.6326% | |
| -39.4309% | |
| 22.6894% | |
| -2.3198% | |
| 20.3768% | |
| 17.2821% | |
| -14.2585% | |
| 22.1954% | |
| 14.0047% | |
| 18.4463% | |
| 25.0619% | |
| 13.13% | |
| 13.6793% | |
| 17.9599% | |
| 13.9107% | |
| 17.7404% | |
| 16.0565% | |
| 15.6984% | |
| 24.7432% | |
| 25.8648% | |
| 30.8683% | |
| 23.04% | |
| 6.55% | |
| -16.2033% |